Ortin Global Ltd (ORTINGLOBE) is currently trading at 14.49 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Ortin Global Limited is a pharmaceutical manufacturer and trader originally incorporated in 1986, producing finished formulations including tablets, capsules, syrups, dry powders and ointments, and exporting products to Asian, African and Middle Eastern markets while holding WHO GMP–standard manufacturing infrastructure at its Medak facility. The company reported unaudited results for quarter ended 30.06.2026 showing Total Income of 1.60 and a loss after tax of -33.79, with Total Expenses of 35.06 driven by a large 'Other Expenditure' head; these figures indicate acute operating cash burn and a markedly thin revenue base relative to reported expenses. Ortin retains strategic assets and plans: historically allotted 6.18 acres by APIIC and publicly stated intent to construct USFDA and European-standard bulk drug manufacturing facilities, suggesting management aims to upgrade capabilities to serve regulated markets and higher value contract manufacturing segments. Despite manufacturing scale and export history, the company shows stressed financial position with Other Equity deeply negative, quarterly losses, and limited income visibility; the auditors issued a limited review with no modification, but the financial trajectory signals urgent need for revenue scaling and expense rationalization.

Over the past 52 weeks, Ortin Global Ltd has traded between a low of ₹11.36 and a high of ₹21.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Ortin Global Ltd has a market capitalization of approximately 11.78. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Ortin Global Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -17.58 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 11.78 Cr, Ortin Global Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Ortin Global Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Ortin Global Ltd is -17.58. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Yes. Ortin Global reported net sales and income from operations of Rs 3.14 lakh for the quarter ended September 30, 2026, compared with Rs 1.16 lakh in the preceding quarter. It was also above Rs 1.40 lakh in the quarter ended September 30, 2025.

Mathesh & Ramana said it was preoccupied with other professional assignments. Its resignation letter was dated November 11, 2026, and the resignation took effect on November 12, 2026.

Ortin Global is scheduled to consider its unaudited standalone September 2026 quarter and half-year results on November 11, 2026. The available filing is a board-meeting intimation and does not contain the financial results themselves.

Ortin Global Limited has scheduled a board meeting on May 30, 2026.